HUP9903839A2 - Pharmaceutical compositions containing (s)-oxybutynin and (s)-desethyloxybutynin for the treatment of urinary incontinence - Google Patents
Pharmaceutical compositions containing (s)-oxybutynin and (s)-desethyloxybutynin for the treatment of urinary incontinenceInfo
- Publication number
- HUP9903839A2 HUP9903839A2 HU9903839A HUP9903839A HUP9903839A2 HU P9903839 A2 HUP9903839 A2 HU P9903839A2 HU 9903839 A HU9903839 A HU 9903839A HU P9903839 A HUP9903839 A HU P9903839A HU P9903839 A2 HUP9903839 A2 HU P9903839A2
- Authority
- HU
- Hungary
- Prior art keywords
- desethyloxybutynin
- oxybutynin
- urinary incontinence
- treatment
- pharmaceutical compositions
- Prior art date
Links
- SNIBJKHIKIIGPR-HXUWFJFHSA-N 4-(ethylamino)but-2-ynyl (2s)-2-cyclohexyl-2-hydroxy-2-phenylacetate Chemical compound C1([C@@](O)(C(=O)OCC#CCNCC)C=2C=CC=CC=2)CCCCC1 SNIBJKHIKIIGPR-HXUWFJFHSA-N 0.000 title abstract 4
- 206010046543 Urinary incontinence Diseases 0.000 title abstract 2
- SWIJYDAEGSIQPZ-VZYDHVRKSA-N esoxybutynin chloride Chemical compound Cl.C1([C@@](O)(C(=O)OCC#CCN(CC)CC)C=2C=CC=CC=2)CCCCC1 SWIJYDAEGSIQPZ-VZYDHVRKSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 2
- 230000002411 adverse Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000007905 soft elastic gelatin capsule Substances 0.000 abstract 1
- 230000037317 transdermal delivery Effects 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Treating urinary incontinence while avoiding concomitant liability of adverse effects comprises administration of 100 mg/day - 1 g/day (S)-oxybutynin (I) or (S)-desethyloxybutynin (II) or their salts. Also claimed are a transdermal delivery device or tablets or a soft elastic gelatin capsules comprising a carrier and 0.1-500 mg (I) or (II) or their salts.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9711570A | 1970-12-11 | 1970-12-11 | |
US08/671,976 US5736577A (en) | 1995-01-31 | 1996-06-28 | Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP9903839A2 true HUP9903839A2 (en) | 2000-03-28 |
HUP9903839A3 HUP9903839A3 (en) | 2000-04-28 |
Family
ID=26792614
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9903839A HUP9903839A3 (en) | 1970-12-11 | 1997-06-27 | Pharmaceutical compositions containing (s)-oxybutynin and (s)-desethyloxybutynin for the treatment of urinary incontinence |
Country Status (1)
Country | Link |
---|---|
HU (1) | HUP9903839A3 (en) |
-
1997
- 1997-06-27 HU HU9903839A patent/HUP9903839A3/en unknown
Also Published As
Publication number | Publication date |
---|---|
HUP9903839A3 (en) | 2000-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS51118839A (en) | Amino acid pharmacy for liverish patient dosage | |
RU99101790A (en) | METHOD FOR TREATING URINE INCOMPOSITION USING (S) -OXIBUTININ AND (S) -DESETHYLOXIBUTININ | |
ES2051881T3 (en) | PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL FORMULATION OF PROLONGED RELEASE. | |
ES2035821T3 (en) | INTEGRATED DIRECTED ADMINISTRATION SYSTEM. | |
CA982478A (en) | Orally administered drug composition for therapy in the treatment of narcotic drug addiction | |
GB1390803A (en) | Medicinal tampons and compositions containing lactulose | |
ES469878A1 (en) | Method of pharmacologically treating drug addiction with alpha-methyl-para-tyrosine | |
IE42950L (en) | X-ray contrast preparations | |
PH9997A (en) | Pharmacologically active n(1h-tetrazol-5-yl)quinaldamide compounds and compositions containing them | |
HUP9903839A2 (en) | Pharmaceutical compositions containing (s)-oxybutynin and (s)-desethyloxybutynin for the treatment of urinary incontinence | |
BE827595A (en) | MEDICINAL PRODUCT FOR ORAL ADMINISTRATION PRODUCING AN ANTIPLASMINE INHIBITOR EFFECT | |
ZA703978B (en) | Device for subcutaneous administration of biologically active substances | |
GB1464467A (en) | Pharmaceutical composition for the treatment of coronary | |
ATE85218T1 (en) | ORAL PHARMACEUTICAL FORM FOR THE TREATMENT OF HYPERTENSION WITH DILTIAZEM HYDROCHLORIDE ONCE DAILY. | |
GB904955A (en) | Pharmaceutical compositions containing phloroglucinol | |
IE35419L (en) | Pharmaceutical composition containing cyclobenzaprine | |
FR2345146A1 (en) | Anorexigenic and lipolytic agent - contg. hydroxy-indanyl propanol for treating obesity | |
GB914512A (en) | Novel therapeutic compositions | |
GB1327465A (en) | Pharmaceutical compositions for inhibiting indoleamine- n-methyl transferase | |
IE36780L (en) | Pharmaceutical preparations | |
FR2077913A1 (en) | Tablets contg gelatine capsules - for administration of liquid medicaments | |
GR3002199T3 (en) | Medicaments containing n-alkyl scopol amine salt and nitroglycerine, method for its preparation and its use | |
ES370500A1 (en) | Procedure for the preparation of the hydracide. (Machine-translation by Google Translate, not legally binding) | |
AU426565B2 (en) | Bandage for administering drugs | |
GB992956A (en) | Pharmaceutical preparations containing pyrrolidone carboxylic acid and salts and esters thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |